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Abstract: The production of pancreatic β cells is the most challenging step for curing diabetes using
next-generation treatments. Adult pancreatic endocrine cells are thought to be maintained by the
self-duplication of differentiated cells, and pancreatic endocrine neogenesis can only be observed
when the tissue is severely damaged. Experimentally, this can be performed using a method named
partial duct ligation (PDL). As the success rate of PDL surgery is low because of difficulties in
identifying the pancreatic duct, we previously proposed a method for fluorescently labeling the
duct in live animals. Using this method, we performed PDL on neurogenin3 (Ngn3)-GFP transgenic
mice to determine the origin of endocrine precursor cells and evaluate their potential to differentiate
into multiple cell types. Ngn3-activated cells, which were marked with GFP, appeared after PDL
operation. Because some GFP-positive cells were aligned proximally to the duct, we hypothesized
that Ngn3-positive cells arise from the pancreatic duct. Therefore, we next developed an in vitro
pancreatic duct culture system using Ngn3-GFP mice and examined whether Ngn3-positive cells
emerge from this duct. We observed GFP expressions in ductal organoid cultures. GFP expressions
were correlated with Ngn3 expressions and endocrine cell lineage markers. Interestingly, tuft cell
markers were also correlated with GFP expressions. Our results demonstrate that in adult mice,
Ngn3-positive endocrine precursor cells arise from the pancreatic ducts both in vivo and in vitro
experiments indicating that the pancreatic duct could be a potential donor for therapeutic use.
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1. Introduction
The pancreas is an organ that serves two vital roles, exocrine and endocrine functions,
which help digestion and regulate blood glucose, respectively. The exocrine part comprises
acinar cells and a ductal system that secretes digestive enzymes and drains into the duodenum. The endocrine compartment of the pancreas consists of islets of Langerhans, which
are composed of five types of endocrine cells: α cells, β cells, δ cells, ε cells, and PP cells.
These cells secrete glucagon, insulin, somatostatin, ghrelin, and pancreatic polypeptide,
respectively [1]. A deficiency in β cells results in diabetes mellitus, for which effective
curative treatment has not been established. One promising therapy is transplantation of
endocrine cells as a substitute for islet cells. However, the generation of β cells either from
embryonic stem cells or induced pluripotent stem cells remains challenging because the
culture conditions for terminal differentiation have not been well-established [2].
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To find other sources of pancreatic stem cells with the potential to become functional
β cells, researchers searched for adult stem cells in the adult pancreas [3]. However, the
β-cell turnover rate is slow, and pancreatic regeneration can only be observed when the
tissue is severely damaged [4]. In contrast, β cells dynamically repopulate in response to
systemic increases in insulin during aging [5], pregnancy [6], obesity [7], and genetic insulin
resistance [8], but the origin of these newly produced β cells is controversial. One group
showed that pre-existing β cells are the major source of new β cells during adult life [4,9].
The other group suggested that β cells form in the adult by transdifferentiation of pancreatic
acinar tissues [10]. Furthermore, another group showed that β cells can be generated from
endogenous progenitors present in pancreatic ducts [11]. The mechanisms leading to
replacement of the endogenous β-cell pool have been studied using chemical [12–14],
genetic [15], and surgical methods such as partial pancreatomy [16] and partial duct
ligation (PDL) [17].
PDL is a suitable model for mimicking human conditions that promote neoplasia;
wide use of this model has provided novel insights into β cell formation. However, the
outcomes of PDL appear to vary between laboratories, and some groups showed that
PDL operation leads to a large increase in the β cell mass [11,15,17–21], whereas other
groups failed to detect new β cells arising from the PDL pancreas [22–24]. The discrepancy
in these results is attributed to the success rate of the operation, as performing PDL is
difficult. To overcome this problem, we established a new technique for PDL using a
simple imaging approach [25]. We examined whether endocrine progenitor cells emerge
from the pancreatic duct after PDL by introducing neurogenin3 (Ngn3)-GFP mice [26], as
Ngn3 is a well-established marker of endocrine progenitor cells [27]. By tracing the GFP
expression after a PDL treatment, we hypothesized that regenerating ductal cells could
give rise to endocrine cell lineages. To examine this hypothesis, we introduced a ductal
organoid culture system to examine whether Ngn3-positive cells emerge accompanied by
endocrine markers as described by Huch et al. in 2013 [19]. To the best of our knowledge,
this is the first study to demonstrate that pancreatic-ductal-derived cells can differentiate
into endocrine lineages.
2. Results
2.1. Observation of Ngn3-Positive Cells in the Ligated Part of the Pancreas at 3, 5, 6, and 21 Days
after Surgery
First, we performed PDL at the tail region of the pancreas in Ngn3-GFP mice. Ngn3positive endocrine precursor cells, marked by GFP, were first observed in the ligated
pancreas 3 days after PDL surgery (day 3, Figure 1B). GFP signals were also found in the
tissues on days 5, 6, and 21 (Figure 1C–F), although we did not detect any GFP signals
in the sham-operated pancreas (Figure 1A). GFP signals were observed outside of the
lining of CK19-positive pancreatic ductal cells (Figure 1B–E). Moreover, we observed some
GFP-positive cells in CK19-positive pancreatic ductal cells (Figure 1D, arrows). To examine
whether Ngn3-positive cells express a definitive marker for islet hormones, we performed
immunohistochemistry analysis but did not detect hormones such as insulin, glucagon, or
somatostatin in Ngn3-positive cells on day 6 (data not shown).
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Figure 2. Generation and characterization of ductal organoid from the pancreas. Pancreatic ducts were dissected from the
pancreas and embedded in Matrigel covered with organoid media to start organoid culture (A). After 2 days, the sheared
end of the duct started proliferating and then formed organoids (B–D, arrowheads). Immunohistochemical analysis of
organoids after 4 days of culture. All cells within the organoids expressed cytokeratin 19 (CK19), a selective ductal marker
(E,F). An acinar cell-specific marker, amylase, was not detected on day 4 (G). (bars: A–D, 500 µm; E, 100 µm; F, 50 µm; G,
30 µm).
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Next, we examined whether Ngn3-GFP-positive cells were present in the ductal organoids. We detected no GFP signal before day 5 in the organoid cultures (Figure 3A).
GFP signals were first observed in the organoids at around days 7–9 (Supplementary Materials Figure S3, Figure 3B). The number of GFP-positive cells increased within the same
organoid up to day 11 (Figure 3B–D).
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components derived from mature acinar or endocrine cells. However, after 3–5 days in
vivo or 7–9 days in organoid culture, we observed the emergence of GFP-positive cells,
indicating Ngn3 was expressed. We further demonstrated by transcriptome analysis that
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Notably, we found that the expression of molecules specific to tuft cells such as
Trpm5, Gnat3, and Pou2f3 [35], was significantly upregulated in correlation with the expression of Ngn3. These results suggest that pancreatic ducts can differentiate into multiple
cell lineages including tuft and endocrine cells. Both cell types emerged from the same
Ngn3-GFP-positive cell fractions, indicating that cell differentiation occurs simultaneously,
although lineage tracing experiments are needed to confirm this. It is natural to observe tuft
cell differentiation in organoid culture because these cells were reported to be present in the
pancreatic duct in mice and humans [35,36]. Recent studies showed that tuft cells trigger
type 2 immunity after parasite infection or when stimulated by succinate [37–40]. Based on
previous studies, we predicted that pancreatic ducts also possess a self-defense function,
likely to protect the tissue from microorganisms and irritants confronted by ductal tuft cells
when the duodenal reflux or pancreatitis occurs. In our future studies, we will establish a
culture method to obtain fully mature endocrine or tuft cells that can respond to nutrients
or hazardous substances. Our in vitro culture methods utilizing Ngn3-GFP transgenic mice
will help to optimize the conditions for cell differentiation, as cell maturation appears to
occur simultaneously. There is, however, a limitation to this study: organoids generated
from pancreatic duct might not always recapitulate in vivo to produce Ngn3-expressing
progenitor cells as we expected. It is important to find the appropriate culture condition
for organoids to differentiate into certain lineages.
In conclusion, we showed both in vivo and in vitro that the pancreatic duct can
produce endocrine progenitor cells that express Ngn3. The organoid culture generated
from the pancreatic duct will be a good model to study endocrine cell differentiation as well
as to understand how the pancreas is regenerated after injury. In the future, the pancreatic
duct organoid will potentially be a new source for endocrine cells for therapeutic usage as
well as in vitro drug screening system to create new drugs for pancreatic cell regeneration.
4. Materials and Methods
4.1. Animals
All animals used in this study were obtained, housed, cared for, and used in accordance with the “Guiding Principles in the Care and Use of Animals” published by
the Animal Care Committee of Tokyo University of Agriculture (Tokyo, Japan, Ethics
identification number: 290084, 28 September 2017). Ngn3-GFP mice were described previously [26]. Mice bred on a C57BL/6 background and crossed with C57BL/6 or ICR mice
were maintained on a 12 h light cycle with access to food and water ad libitum.
4.2. PDL after Cholyl-Lysyl-Fluorescein Injection
A combination anesthetic was prepared from medetomidine (0.3 mg/kg), midazolam
(4.0 mg/kg), and butorphanol (5.0 mg/kg). Medetomidine was purchased from Zenoaq
(Tokyo, Japan). Midazolam was purchased from Sandoz (Tokyo, Japan). Butorphanol
was purchased from Meiji Seika Pharma (Tokyo, Japan). Chlorhexidine gluconate was
purchased from Sumitomo Dainippon Pharma (Osaka, Japan). Cholyl-lysyl-fluorescein was
purchased from Corning (Corning, NY, USA). PDL surgeries were performed as previously
described [25].
4.3. Immunohistochemistry
The following antibodies were used: anti-pancreatic alpha amylase (ab21156, Abcam,
Cambridge, U.K.), anti-insulin (sc-7839, Santa Cruz Biotechnology, Dallas, TX, USA),
anti-somatostatin 28 (ab22682, Abcam), anti-glucagon (ab92517, Abcam), and anti-GFP
(Rockland Immunochemicals, Gilbertsville, PA, USA). Rabbit anti-CK19 antibodies were
a gift from Dr. Atsushi Miyajima (The university of Tokyo) [41,42]. PDL-administered
pancreas or pancreatic organoids from Ngn3-GFP mice (n = 3, respectively) were fixed in
4% paraformaldehyde in phosphate-buffered saline and embedded in O.C.T. compound
(Sakura Finetek, Torrance, CA, USA). Frozen sections (12 µm) were prepared and incubated
in 0.3% Triton X-100 and 2% donkey serum for 1 h, followed by incubation with the primary
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antibodies overnight at 4 ◦ C. Next, the sections were incubated with secondary antibodies
(Alexa Fluor 555 or 594 IgG; Invitrogen, Carlsbad, CA, USA) and counterstained with DAPI
(Nacalai Tesque, Kyoto, Japan).
4.4. Organoid Culture
Ngn3-GFP mouse pancreatic organoids were prepared as previously described [19,43]
with minor modifications. Briefly, the pancreas was dissected and minced into pieces,
followed by incubation with digestion solution (wash medium with 0.125 mg/mL collagenase IV, 0.125 mg/mL dispaseII, and 0.1 mg/mL DNase I) for 1 h at 37 ◦ C. Isolated ducts
were embedded in Matrigel covered with the culture medium (5% R-spondin2-conditioned
medium, 5% Noggin-conditioned medium, 2% B27 supplement (without vitamin A),
100 ng/mL recombinant human FGF10 (Peprotech, Rocky Hill, NJ, USA), 50 ng/mL recombinant mouse epidermal growth factor (Peprotech), 10 mM nicotinamide (FUJIFILM
WAKO, Osaka, Japan), 1 mM N-acetylcysteine (Sigma Aldrich, St. Louis, MO, USA), and
10 nM recombinant human [Leu15]-gastrin1 (Sigma Aldrich) in the basal medium). Every
2–3 days, the medium was replaced with fresh medium.
4.5. RNA-Seq Analysis
Total RNA was extracted from the organoids using ISOGEN (Nippon Gene, Tokyo,
Japan). The quality and quantity of the extracted RNA were determined using a spectrophotometer (Nanodrop 2000, Thermo Fisher Scientific, Waltham, MA, USA) and an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Library preparation was performed using a NEBNext Ultra RNA Library Prep Kit for Illumina (New
England Biolabs, Ipswich, MA, USA) according to the manufacturer’s protocol. The precise
concentration of the libraries was determined using a KAPA Library Quantification Kit
(Kapa Biosystems, Wilmington, MA, USA). All libraries were diluted to a concentration of
10 nM and mixed in equal amounts. The library mixture was sequenced by 1 × 100 base
pair single-read sequencing on an Illumina HiSeq 2500 (Illumina, San Diego, CA, USA).
Reads in FASTQ format were generated using bcl2fastq2 conversion software (Illumina,
version 2.18). The read data were submitted to the DDBJ Read Archive (accession number:
DRA007996). Adapter sequences and the initial 13 bases in each read were removed using
CLC Genomics Workbench 10 software (Qiagen, Hilden, Germany). The cleaned read data
were mapped to the mouse reference genome (GRCm38.p6) retrieved from the Ensembl
genome browser (https://www.ensembl.org/index.html, accessed on 22 November 2018).
Mapping parameters were as follows: mismatch cost, 2; insertion cost, 3; deletion cost, 3;
length fraction, 0.8; and similarity fraction, 0.8.
4.6. Statistical Analysis
Differentially expressed genes of Ngn3-GFP-expressing organoids and control organoids
were identified with significant thresholds of a fold-change ≥ |1.5| and false discovery
rate adjusted p-value (q-value) < 0.05 using a generalized linear model approach using the
CLC Genomics Workbench built-in tools Differential Expression for RNA-Seq.
4.7. Reverse Transcription (RT)-PCR
Organoids were collected after 11 days, and total RNA was extracted using ISOGEN.
The SuperScript III First-Strand Synthesis System for RT-PCR (Thermo Fisher Scientific) was
used to generate cDNA. RT-PCR was performed using primer pairs against the gene of interest (primers are shown in Table S1). RT-PCR was performed as previously described [44]
using primers specific for enteroendocrine and tuft cell markers (Supplementary Materials
Table S1).
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pancreas and day 4 organoids prepared from pancreatic ducts; Figure S3: Changes in the number of
Ngn3-GFP-positive cells within pancreatic organoids generated from Ngn3-GFP mouse; Table S1:
Primers used for RT-PCR.
Author Contributions: Conceptualization, C.K.-N. and K.I.; methodology, C.K.-N., Y.H., and K.K.;
software, K.T.; validation, K.T. and K.I.; formal analysis, K.I.; investigation, C.K.-N. and K.S.; resources, M.M. and Y.O. (Yasushi Okazaki); data curation, T.Y. and Y.O. (Yuichi Oishi); writing—
original draft preparation, C.K.-N.; writing—review and editing, K.I.; visualization, C.K.-N.; supervision, K.I.; project administration, K.I.; funding acquisition, K.I. All authors have read and agreed to
the published version of the manuscript.
Funding: This work was funded by JSPS KAKENHI (26892026 to Ken Iwatsuki) and by a Grant-inAid for Advanced Research Project from Tokyo University of Agriculture (to Ken Iwatsuki).
Institutional Review Board Statement: The study was approved by the Animal Care Committee of
Tokyo University of Agriculture (#140014) and animals were obtained, housed, cared for and used
in accordance with the “Guiding Principles in the Care and Use of Animals” published by Tokyo
University of Agriculture.
Informed Consent Statement: Not applicable.
Data Availability Statement: All the data are shown in the main manuscript and in the Supplementary Materials.
Acknowledgments: We thank H. Clevers for the Noggin-producing cell line and J. Whitsett for the
R-spondin2-producing cell line. We also thank A. Miyajima for providing CK19 antibodies.
Conflicts of Interest: The authors declare no conflict of interest.

References
1.
2.

3.
4.
5.
6.
7.
8.
9.
10.
11.

12.
13.
14.

Zhou, Q.; Melton, D.A. Pancreas regeneration. Nature 2018, 557, 351–358. [CrossRef]
Loomans, C.J.M.; Williams Giuliani, N.; Balak, J.; Ringnalda, F.; van Gurp, L.; Huch, M.; Boj, S.F.; Sato, T.; Kester, L.; de Sousa
Lopes, S.M.C.; et al. Expansion of adult human pancreatic tissue yields organoids harboring progenitor cells with endocrine
differentiation potential. Stem Cell Rep. 2018, 10, 712–724. [CrossRef]
Kopp, J.L.; Grompe, M.; Sander, M. Stem cells versus plasticity in liver and pancreas regeneration. Nat. Cell Biol. 2016, 18, 238–245.
[CrossRef]
Dor, Y.; Brown, J.; Martinez, O.I.; Melton, D.A. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell
differentiation. Nature 2004, 429, 41–46. [CrossRef]
Matveyenko, A.V.; Veldhuis, J.D.; Butler, P.C. Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and β-cell mass
to age-related insulin resistance in rats. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E832–E841. [CrossRef]
Sorenson, R.L.; Brelje, T.C. Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the
role of lactogenic hormones. Horm. Metab. Res. 1997, 29, 301–307. [CrossRef] [PubMed]
Kloppel, G.; Lohr, M.; Habich, K.; Oberholzer, M.; Heitz, P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes
mellitus revisited. Surv. Synth. Pathol. Res. 1985, 4, 110–125.
Bruning, J.C.; Winnay, J.; Bonner-Weir, S.; Taylor, S.I.; Accili, D.; Kahn, C.R. Development of a novel polygenic model of NIDDM
in mice heterozygous for IR and IRS-1 null alleles. Cell 1997, 88, 561–572. [CrossRef]
Teta, M.; Rankin, M.M.; Long, S.Y.; Stein, G.M.; Kushner, J.A. Growth and regeneration of adult beta cells does not involve
specialized progenitors. Dev. Cell 2007, 12, 817–826. [CrossRef] [PubMed]
Lipsett, M.; Finegood, D.T. β-cell neogenesis during prolonged hyperglycemia in rats. Diabetes 2002, 51, 1834–1841. [CrossRef]
[PubMed]
Xu, X.; D’Hoker, J.; Stange, G.; Bonne, S.; De Leu, N.; Xiao, X.; Van de Casteele, M.; Mellitzer, G.; Ling, Z.; Pipeleers, D.; et al.
β cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132, 197–207. [CrossRef]
[PubMed]
Nir, T.; Melton, D.A.; Dor, Y. Recovery from diabetes in mice by. β cell regeneration. J. Clin. Invest. 2007, 117, 2553–2561.
[CrossRef] [PubMed]
Szkudelski, T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001, 50, 537–546.
Thorel, F.; Damond, N.; Chera, S.; Wiederkehr, A.; Thorens, B.; Meda, P.; Wollheim, C.B.; Herrera, P.L. Normal glucagon signaling
and β-cell function after near-total α-cell ablation in adult mice. Diabetes 2011, 60, 2872–2882. [CrossRef] [PubMed]

Int. J. Mol. Sci. 2021, 22, 8548

15.

16.
17.
18.

19.

20.

21.

22.
23.

24.
25.
26.

27.
28.
29.
30.
31.

32.

33.

34.
35.
36.
37.
38.

10 of 11

Inada, A.; Nienaber, C.; Katsuta, H.; Fujitani, Y.; Levine, J.; Morita, R.; Sharma, A.; Bonner-Weir, S. Carbonic anhydrase II-positive
pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl. Acad. Sci. USA 2008, 105,
19915–19919. [CrossRef] [PubMed]
Li, W.C.; Rukstalis, J.M.; Nishimura, W.; Tchipashvili, V.; Habener, J.F.; Sharma, A.; Bonner-Weir, S. Activation of pancreatic-ductderived progenitor cells during pancreas regeneration in adult rats. J. Cell Sci. 2010, 123, 2792–2802. [CrossRef]
Wang, R.N.; Kloppel, G.; Bouwens, L. Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats.
Diabetologia 1995, 38, 1405–1411. [CrossRef]
Criscimanna, A.; Speicher, J.A.; Houshmand, G.; Shiota, C.; Prasadan, K.; Ji, B.; Logsdon, C.D.; Gittes, G.K.; Esni, F. Duct cells
contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology 2011, 141,
1451–1462.e6. [CrossRef] [PubMed]
Huch, M.; Bonfanti, P.; Boj, S.F.; Sato, T.; Loomans, C.J.; van de Wetering, M.; Sojoodi, M.; Li, V.S.; Schuijers, J.; Gracanin, A.;
et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J. 2013, 32,
2708–2721. [CrossRef]
Pan, F.C.; Bankaitis, E.D.; Boyer, D.; Xu, X.; Van de Casteele, M.; Magnuson, M.A.; Heimberg, H.; Wright, C.V. Spatiotemporal
patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration.
Development 2013, 140, 751–764. [CrossRef]
Van de Casteele, M.; Leuckx, G.; Baeyens, L.; Cai, Y.; Yuchi, Y.; Coppens, V.; De Groef, S.; Eriksson, M.; Svensson, C.; Ahlgren, U.;
et al. Neurogenin 3+ cells contribute to β-cell neogenesis and proliferation in injured adult mouse pancreas. Cell Death Dis. 2013,
4, e523. [CrossRef]
Chintinne, M.; Stange, G.; Denys, B.; Ling, Z.; ’t Veld, P.; Pipeleers, D. Beta cell count instead of beta cell mass to assess and
localize growth in beta cell population following pancreatic duct ligation in mice. PLoS ONE 2012, 7, e43959. [CrossRef]
Kopp, J.L.; Dubois, C.L.; Schaffer, A.E.; Hao, E.; Shih, H.P.; Seymour, P.A.; Ma, J.; Sander, M. Sox9+ ductal cells are multipotent
progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development
2011, 138, 653–665. [CrossRef] [PubMed]
Rankin, M.M.; Wilbur, C.J.; Rak, K.; Shields, E.J.; Granger, A.; Kushner, J.A. β-Cells are not generated in pancreatic duct
ligation-induced injury in adult mice. Diabetes 2013, 62, 1634–1645. [CrossRef]
Nakajima, C.; Kamimoto, K.; Miyajima, K.; Matsumoto, M.; Okazaki, Y.; Kobayashi-Hattori, K.; Shimizu, M.; Yamane, T.; Oishi, Y.;
Iwatsuki, K. A method for identifying mouse pancreatic ducts. Tissue Eng. C Methods 2018, 24, 480–485. [CrossRef] [PubMed]
Jiang, F.X.; Li, K.; Archer, M.; Mehta, M.; Jamieson, E.; Charles, A.; Dickinson, J.E.; Matsumoto, M.; Morahan, G. Differentiation of
Islet Progenitors Regulated by Nicotinamide into Transcriptome-Verified beta Cells That Ameliorate Diabetes. Stem Cells 2017, 35,
1341–1354. [CrossRef] [PubMed]
Gradwohl, G.; Dierich, A.; LeMeur, M.; Guillemot, F. Neurogenin3 is required for the development of the four endocrine cell
lineages of the pancreas. Proc. Natl. Acad. Sci. USA 2000, 97, 1607–1611. [CrossRef] [PubMed]
Tanaka, A.; Watanabe, A.; Nakano, Y.; Matsumoto, M.; Okazaki, Y.; Miyajima, A. Reversible expansion of pancreatic islet
progenitors derived from human induced pluripotent stem cells. Genes Cells 2020, 25, 302–311. [CrossRef] [PubMed]
Van de Casteele, M.; Leuckx, G.; Cai, Y.; Yuchi, Y.; Coppens, V.; De Groef, S.; Van Gassen, N.; Baeyens, L.; Heremans, Y.; Wright,
C.V.; et al. Partial duct ligation: β-Cell proliferation and beyond. Diabetes 2014, 63, 2567–2577. [CrossRef] [PubMed]
Shih, H.P.; Kopp, J.L.; Sandhu, M.; Dubois, C.L.; Seymour, P.A.; Grapin-Botton, A.; Sander, M. A notch-dependent molecular
circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 2012, 139, 2488–2499. [CrossRef] [PubMed]
Minami, K.; Okuno, M.; Miyawaki, K.; Okumachi, A.; Ishizaki, K.; Oyama, K.; Kawaguchi, M.; Ishizuka, N.; Iwanaga, T.; Seino, S.
Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells. Proc. Natl. Acad. Sci.
USA 2005, 102, 15116–15121. [CrossRef] [PubMed]
Miyamoto, Y.; Maitra, A.; Ghosh, B.; Zechner, U.; Argani, P.; Iacobuzio-Donahue, C.A.; Sriuranpong, V.; Iso, T.; Meszoely, I.M.;
Wolfe, M.S.; et al. Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer
Cell 2003, 3, 565–576. [CrossRef]
Miyatsuka, T.; Kaneto, H.; Shiraiwa, T.; Matsuoka, T.A.; Yamamoto, K.; Kato, K.; Nakamura, Y.; Akira, S.; Takeda, K.; Kajimoto, Y.;
et al. Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation. Genes Dev. 2006,
20, 1435–1440. [CrossRef] [PubMed]
Rooman, I.; Heremans, Y.; Heimberg, H.; Bouwens, L. Modulation of rat pancreatic acinoductal transdifferentiation and expression
of PDX-1 in vitro. Diabetologia 2000, 43, 907–914. [CrossRef]
Schutz, B.; Ruppert, A.L.; Strobel, O.; Lazarus, M.; Urade, Y.; Buchler, M.W.; Weihe, E. Distribution pattern and molecular
signature of cholinergic tuft cells in human gastro-intestinal and pancreatic-biliary tract. Sci. Rep. 2019, 9, 17466. [CrossRef]
Hofer, D.; Drenckhahn, D. Identification of the taste cell G-protein, α-gustducin, in brush cells of the rat pancreatic duct system.
Histochem. Cell Biol. 1998, 110, 303–309. [CrossRef]
Von Moltke, J.; Ji, M.; Liang, H.E.; Locksley, R.M. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit.
Nature 2016, 529, 221–225. [CrossRef]
Gerbe, F.; Sidot, E.; Smyth, D.J.; Ohmoto, M.; Matsumoto, I.; Dardalhon, V.; Cesses, P.; Garnier, L.; Pouzolles, M.; Brulin, B.;
et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 2016, 529, 226–230. [CrossRef]
[PubMed]

Int. J. Mol. Sci. 2021, 22, 8548

39.

40.

41.
42.
43.

44.

11 of 11

Howitt, M.R.; Lavoie, S.; Michaud, M.; Blum, A.M.; Tran, S.V.; Weinstock, J.V.; Gallini, C.A.; Redding, K.; Margolskee, R.F.;
Osborne, L.C.; et al. Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. Science 2016, 351,
1329–1333. [CrossRef]
Nadjsombati, M.S.; McGinty, J.W.; Lyons-Cohen, M.R.; Jaffe, J.B.; DiPeso, L.; Schneider, C.; Miller, C.N.; Pollack, J.L.; Nagana
Gowda, G.A.; Fontana, M.F.; et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity
2018, 49, 33–41.e7. [CrossRef]
Kaneko, K.; Kamimoto, K.; Miyajima, A.; Itoh, T. Adaptive remodeling of the biliary architecture underlies liver homeostasis.
Hepatology 2015, 61, 2056–2066. [CrossRef] [PubMed]
Tanimizu, N.; Nishikawa, M.; Saito, H.; Tsujimura, T.; Miyajima, A. Isolation of hepatoblasts based on the expression of Dlk/Pref-1.
J. Cell Sci. 2003, 116, 1775–1786. [CrossRef] [PubMed]
Broutier, L.; Andersson-Rolf, A.; Hindley, C.J.; Boj, S.F.; Clevers, H.; Koo, B.K.; Huch, M. Culture and establishment of selfrenewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat. Protoc. 2016, 11,
1724–1743. [CrossRef] [PubMed]
Iwatsuki, K.; Oda, M.; Sun, W.; Tanaka, S.; Ogawa, T.; Shiota, K. Molecular cloning and characterization of a new member of the
rat placental prolactin (PRL) family, PRL-like protein H. Endocrinology 1998, 139, 4976–4983. [CrossRef] [PubMed]

